Treeline Biosciences
Developer of transformative precision medicines intended to treat cancer and other serious conditions. The company's platform is involved in assessments of normal and disease pathophysiology, experime...
Valuation
$0
Share Price
N/A
Total Raised
$1.1B
Last Round
N/A